Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
AKAN vs TLRY
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
AKAN vs TLRY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1M | $660M |
| Revenue (TTM) | $2M | $1.17B |
| Net Income (TTM) | $-31M | $-2.95B |
| Gross Margin | -43.7% | 28.0% |
| Operating Margin | -6.3% | -266.0% |
| Total Debt | $353K | $451M |
| Cash & Equiv. | $4M | $304M |
AKAN vs TLRY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| Akanda Corp. (AKAN) | 100 | 0.0 | -100.0% |
| Tilray Brands, Inc. (TLRY) | 100 | 72.8 | -27.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AKAN vs TLRY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AKAN is the clearest fit if your priority is income & stability and growth exposure.
- beta 1.71
- Rev growth -61.3%, EPS growth 100.0%, 3Y rev CAGR 172.3%
- Lower volatility, beta 1.71, Low D/E 8.3%, current ratio 1.39x
TLRY carries the broadest edge in this set and is the clearest fit for long-term compounding.
- -74.7% 10Y total return vs AKAN's -100.0%
- 4.8% revenue growth vs AKAN's -61.3%
- -252.6% margin vs AKAN's -19.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.8% revenue growth vs AKAN's -61.3% | |
| Quality / Margins | -252.6% margin vs AKAN's -19.6% | |
| Stability / Safety | Beta 1.71 vs TLRY's 2.03, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +12.1% vs AKAN's -46.1% | |
| Efficiency (ROA) | -100.6% ROA vs AKAN's -380.2%, ROIC -66.2% vs -7.5% |
AKAN vs TLRY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AKAN vs TLRY — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
TLRY leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TLRY is the larger business by revenue, generating $1.2B annually — 730.4x AKAN's $2M. TLRY is the more profitable business, keeping -2.5% of every revenue dollar as net income compared to AKAN's -19.6%. On growth, TLRY holds the edge at +3.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2M | $1.2B |
| EBITDAEarnings before interest/tax | -$8M | -$3.0B |
| Net IncomeAfter-tax profit | -$31M | -$2.9B |
| Free Cash FlowCash after capex | -$7M | -$94M |
| Gross MarginGross profit ÷ Revenue | -43.7% | +28.0% |
| Operating MarginEBIT ÷ Revenue | -6.3% | -2.7% |
| Net MarginNet income ÷ Revenue | -19.6% | -2.5% |
| FCF MarginFCF ÷ Revenue | -4.4% | -8.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +3.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +88.4% | +70.7% |
Valuation Metrics
TLRY leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1M | $660M |
| Enterprise ValueMkt cap + debt − cash | -$2M | $806M |
| Trailing P/EPrice ÷ TTM EPS | -0.14x | -0.17x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 1.44x | 0.59x |
| Price / BookPrice ÷ Book value/share | 0.14x | 0.25x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
AKAN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
TLRY delivers a -136.5% return on equity — every $100 of shareholder capital generates $-137 in annual profit, vs $-15 for AKAN. AKAN carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to TLRY's 0.22x. On the Piotroski fundamental quality scale (0–9), AKAN scores 5/9 vs TLRY's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -15.1% | -136.5% |
| ROA (TTM)Return on assets | -3.8% | -100.6% |
| ROICReturn on invested capital | -7.5% | -66.2% |
| ROCEReturn on capital employed | -3.0% | -78.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.08x | 0.22x |
| Net DebtTotal debt minus cash | -$3M | $147M |
| Cash & Equiv.Liquid assets | $4M | $304M |
| Total DebtShort + long-term debt | $352,814 | $451M |
| Interest CoverageEBIT ÷ Interest expense | -47.93x | -89.43x |
Total Returns (Dividends Reinvested)
TLRY leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TLRY five years ago would be worth $3,498 today (with dividends reinvested), compared to $1 for AKAN. Over the past 12 months, TLRY leads with a +1209.3% total return vs AKAN's -46.1%. The 3-year compound annual growth rate (CAGR) favors TLRY at 26.7% vs AKAN's -80.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +277.9% | -41.8% |
| 1-Year ReturnPast 12 months | -46.1% | +1209.3% |
| 3-Year ReturnCumulative with dividends | -99.3% | +103.6% |
| 5-Year ReturnCumulative with dividends | -100.0% | -65.0% |
| 10-Year ReturnCumulative with dividends | -100.0% | -74.7% |
| CAGR (3Y)Annualised 3-year return | -80.5% | +26.7% |
Risk & Volatility
Evenly matched — AKAN and TLRY each lead in 1 of 2 comparable metrics.
Risk & Volatility
AKAN is the less volatile stock with a 1.71 beta — it tends to amplify market swings less than TLRY's 2.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TLRY currently trades 36.1% from its 52-week high vs AKAN's 20.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.71x | 2.03x |
| 52-Week HighHighest price in past year | $185.80 | $15.70 |
| 52-Week LowLowest price in past year | $1.41 | $0.35 |
| % of 52W HighCurrent price vs 52-week peak | +20.0% | +36.1% |
| RSI (14)Momentum oscillator 0–100 | 61.0 | 37.9 |
| Avg Volume (50D)Average daily shares traded | 2.7M | 4.7M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $10.00 |
| # AnalystsCovering analysts | — | 20 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
TLRY leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). AKAN leads in 1 (Profitability & Efficiency). 1 tied.
AKAN vs TLRY: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is AKAN or TLRY a better buy right now?
For growth investors, Tilray Brands, Inc.
(TLRY) is the stronger pick with 4. 8% revenue growth year-over-year, versus -61. 3% for Akanda Corp. (AKAN). Analysts rate Tilray Brands, Inc. (TLRY) a "Hold" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AKAN or TLRY?
Over the past 5 years, Tilray Brands, Inc.
(TLRY) delivered a total return of -65. 0%, compared to -100. 0% for Akanda Corp. (AKAN). Over 10 years, the gap is even starker: TLRY returned -74. 7% versus AKAN's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AKAN or TLRY?
By beta (market sensitivity over 5 years), Akanda Corp.
(AKAN) is the lower-risk stock at 1. 71β versus Tilray Brands, Inc. 's 2. 03β — meaning TLRY is approximately 19% more volatile than AKAN relative to the S&P 500. On balance sheet safety, Akanda Corp. (AKAN) carries a lower debt/equity ratio of 8% versus 22% for Tilray Brands, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AKAN or TLRY?
By revenue growth (latest reported year), Tilray Brands, Inc.
(TLRY) is pulling ahead at 4. 8% versus -61. 3% for Akanda Corp. (AKAN). On earnings-per-share growth, the picture is similar: Akanda Corp. grew EPS 100. 0% year-over-year, compared to -651. 7% for Tilray Brands, Inc.. Over a 3-year CAGR, AKAN leads at 172. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AKAN or TLRY?
Tilray Brands, Inc.
(TLRY) is the more profitable company, earning -266. 3% net margin versus -489. 6% for Akanda Corp. — meaning it keeps -266. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TLRY leads at -277. 9% versus -523. 8% for AKAN. At the gross margin level — before operating expenses — TLRY leads at 29. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — AKAN or TLRY?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is AKAN or TLRY better for a retirement portfolio?
For long-horizon retirement investors, Akanda Corp.
(AKAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Tilray Brands, Inc. (TLRY) carries a higher beta of 2. 03 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AKAN: -100. 0%, TLRY: -74. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between AKAN and TLRY?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.